Adenomyosis in Fertile Women in MUSA Criteria
Application of the Revised Morphological Uterus Sonographic Assessment (MUSA) Criteria to Diagnose Adenomyosis in Fertile Women
1 other identifier
observational
144
1 country
1
Brief Summary
- 1.To estimate the prevalence of adenomyosis in fertile women aged 18-30 years using the revised MUSA ultrasound criteria.
- 2.To evaluate clinical risk factors that are associated with adenomyosis diagnosis in this population
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for all trials
Started Feb 2024
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
January 26, 2024
CompletedStudy Start
First participant enrolled
February 1, 2024
CompletedFirst Posted
Study publicly available on registry
February 9, 2024
CompletedPrimary Completion
Last participant's last visit for primary outcome
June 1, 2025
CompletedStudy Completion
Last participant's last visit for all outcomes
July 1, 2025
CompletedFebruary 9, 2024
February 1, 2024
1.3 years
January 26, 2024
February 1, 2024
Conditions
Outcome Measures
Primary Outcomes (1)
adenomyosis in fertile women
Estimation of the prevalence of adenomyosis diagnosed using revised MUSA criteria among fertile women aged 18-30 years.
1.5 year
Study Arms (2)
first group
women with with adenomyosis
second group
women without adenomyosis
Eligibility Criteria
The study will include women with regular menstrual cycle attending outpatient clinic for contraception counseling( age 18 -30 years old ; written consent will be obtained )
You may qualify if:
- women with regular menstrual cycle attending outpatient clinic for contraception counseling
- age 18 -30 years old
You may not qualify if:
- Women on hormonal contraception
- Infertile women
- Associated pathologies like endometriosis, uterine fibroids. and ovarian cysts
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Assuit university
Asyut, 71515, Egypt
Related Publications (4)
Marion LL, Meeks GR. Ectopic pregnancy: History, incidence, epidemiology, and risk factors. Clin Obstet Gynecol. 2012 Jun;55(2):376-86. doi: 10.1097/GRF.0b013e3182516d7b.
PMID: 22510618BACKGROUNDPractice Committee of American Society for Reproductive Medicine. Medical treatment of ectopic pregnancy. Fertil Steril. 2008 Nov;90(5 Suppl):S206-12. doi: 10.1016/j.fertnstert.2008.08.049.
PMID: 19007632BACKGROUNDKarol D, Williamson M, Pereira N. Successful Expectant Management of a Tubal Ectopic Pregnancy. J Minim Invasive Gynecol. 2024 Feb;31(2):92-94. doi: 10.1016/j.jmig.2023.11.011. Epub 2023 Nov 30. No abstract available.
PMID: 38042476BACKGROUNDHarmsen MJ, Van den Bosch T, de Leeuw RA, Dueholm M, Exacoustos C, Valentin L, Hehenkamp WJK, Groenman F, De Bruyn C, Rasmussen C, Lazzeri L, Jokubkiene L, Jurkovic D, Naftalin J, Tellum T, Bourne T, Timmerman D, Huirne JAF. Consensus on revised definitions of Morphological Uterus Sonographic Assessment (MUSA) features of adenomyosis: results of modified Delphi procedure. Ultrasound Obstet Gynecol. 2022 Jul;60(1):118-131. doi: 10.1002/uog.24786.
PMID: 34587658BACKGROUND
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- STUDY DIRECTOR
safwat abdelrady, Prof
Assiut University
Central Study Contacts
Study Design
- Study Type
- observational
- Observational Model
- OTHER
- Time Perspective
- CROSS SECTIONAL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- principal invistigator
Study Record Dates
First Submitted
January 26, 2024
First Posted
February 9, 2024
Study Start
February 1, 2024
Primary Completion
June 1, 2025
Study Completion
July 1, 2025
Last Updated
February 9, 2024
Record last verified: 2024-02
Data Sharing
- IPD Sharing
- Will not share